ELI LILLY & Co — Director's Dealing 2013

Jan 29, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2013-01-25

Reporting Person: Simmons Jeffrey N (SVP&Pres.,Elanco Animal Health)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-01-25	Common Stock	A	19735	$53.21	Acquired	46917	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-01-25	Restricted Stock Unit	$	A	9405	Acquired	2014-02-01	Common Stock (9405)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	933	Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.